Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Hattori

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Modern Rheumatology|August 17, 2022
Reasons and risk factors for discontinuation of treatment with any biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: A long-term observational studyKenya Terabe, Nobunori Takahashi, Shuji Asai, et al.
Modern Rheumatology|May 3, 2017
High rate of improvement in serum matrix metalloproteinase-3 levels at 4 weeks predicts remission at 52 weeks in RA patients treated with adalimumabYosuke Hattori, Toshihisa Kojima, Atsushi Kaneko, et al.
The Journal of Rheumatology|June 17, 2016
Longterm Retention Rate and Risk Factors for Adalimumab Discontinuation Due To Efficacy and Safety in Japanese Patients with Rheumatoid Arthritis: An Observational Cohort StudyYosuke Hattori, Toshihisa Kojima, Atsushi Kaneko, et al.
Modern Rheumatology|October 27, 2012
Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritisToshihisa Kojima, Yuichiro Yabe, Atsushi Kaneko, et al.
Modern Rheumatology|August 8, 2019
Discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab: An interventional studyShuji Asai, Masatoshi Hayashi, Masahiro Hanabayashi, et al.
Modern Rheumatology|September 15, 2012
Clinical efficacy of abatacept in Japanese rheumatoid arthritis patientsNobunori Takahashi, Toshihisa Kojima, Kenya Terabe, et al.
Joint Bone Spine|June 14, 2020
Predictors of disease flare after discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumabShuji Asai, Nobunori Takahashi, Masatoshi Hayashi, et al.
Clinical Rheumatology|September 24, 2013
Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activityNobunori Takahashi, Toshihisa Kojima, Atsushi Kaneko, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Modern Rheumatology|August 17, 2022
Reasons and risk factors for discontinuation of treatment with any biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: A long-term observational studyKenya Terabe, Nobunori Takahashi, Shuji Asai, et al.
Modern Rheumatology|May 3, 2017
High rate of improvement in serum matrix metalloproteinase-3 levels at 4 weeks predicts remission at 52 weeks in RA patients treated with adalimumabYosuke Hattori, Toshihisa Kojima, Atsushi Kaneko, et al.
The Journal of Rheumatology|June 17, 2016
Longterm Retention Rate and Risk Factors for Adalimumab Discontinuation Due To Efficacy and Safety in Japanese Patients with Rheumatoid Arthritis: An Observational Cohort StudyYosuke Hattori, Toshihisa Kojima, Atsushi Kaneko, et al.
Modern Rheumatology|October 27, 2012
Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritisToshihisa Kojima, Yuichiro Yabe, Atsushi Kaneko, et al.
Modern Rheumatology|August 8, 2019
Discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab: An interventional studyShuji Asai, Masatoshi Hayashi, Masahiro Hanabayashi, et al.
Modern Rheumatology|September 15, 2012
Clinical efficacy of abatacept in Japanese rheumatoid arthritis patientsNobunori Takahashi, Toshihisa Kojima, Kenya Terabe, et al.
Joint Bone Spine|June 14, 2020
Predictors of disease flare after discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumabShuji Asai, Nobunori Takahashi, Masatoshi Hayashi, et al.
Clinical Rheumatology|September 24, 2013
Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activityNobunori Takahashi, Toshihisa Kojima, Atsushi Kaneko, et al.
Pageof 4